Brind.

Dr. Kirk Shepard joined BP Logix's Life Sciences Strategic Advisory Board, leveraging his extensive background in the pharmaceutical industry.

1 report, 1 independent Updated Aug 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Boehringer Ingelheim Baxter International Eisai

Keep exploring

The entities involved

Boehringer Ingelheim
German pharmaceutical company
- Sheila Denton was appointed as General Counsel & Corporate Secretary at Boehringer Ingelheim.Mon 15:03
- Boehringer Ingelheim and Palatin Technologies reported $13.2 million in revenue from their Fiscal 2026 collaboration.Mon 13:31
Baxter International
American manufacturer of healthcare goods

Nothing else this week.
Eisai
Japanese pharmaceutical company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 26Business WireMedical Affairs Leader Dr. Kirk Shepard Joins BP Logix’s Life Sciences Strategic Advisory Board Renowned Medical Affairs executive and MAPS co-founder Dr. Kirk Shepard steps up to help guide the next